Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist

Anna-Maria South; Laura Fanucchi; Michelle Lofwall

doi:10.1001/jama.2023.5904

Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist

JAMA. 2023 May 23;329(20):1738-1739. doi: 10.1001/jama.2023.5904.

Authors

Anna-Maria South¹, Laura Fanucchi², Michelle Lofwall³

Affiliations

¹ Department of Internal Medicine, Division of Hospital Medicine, Addiction Consult and Education Service, University of Kentucky College of Medicine, Lexington.
² Department of Internal Medicine, Division of Infectious Diseases, Addiction Consult and Education Service, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington.
³ Departments of Behavioral Science and Psychiatry, First Bridge and Straus Clinics, Center on Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington.

PMID: 37093586
DOI: 10.1001/jama.2023.5904

No abstract available

Plain language summary

This Viewpoint discusses the importance of ensuring that life-saving medication for opioid use disorder is available to hospitalized persons who are incarcerated.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Analgesics, Opioid / therapeutic use
Buprenorphine* / therapeutic use
Hospitalists* / ethics
Humans
Methadone / therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders* / drug therapy
Prisoners*

Substances

Analgesics, Opioid
Buprenorphine
Methadone